MOPEAD newsletter 01

Saturday 21st September marks World Alzheimer Day 2019, an important international event which aims to raise awareness about dementia. Over the whole month of September, Alzheimer’s Disease International (ADI) launched a global campaign under the them...

We are thrilled to announce that MOPEAD has been named a finalist in the Health category of The Internet Awards! 

The purpose of the Internet Awards is to recognise initiatives, people or organisations that have most stood out during the year in t...

You can now vote for MOPEAD at the XXIV edition of the Internet Awards! MOPEAD has been nominated for best Entrepreneurship and Research for Health in celebration of #diadeinternet (World Internet Day) which takes place on May 17th. 

You can vote for M...

A delegation from Fundació ACE participated this week in the biannual meeting of the European Alzheimer's Disease Consortium (EADC) in Leipzig (Germany). At the meeting, that took place on April 11th -12th, Dr. Mercè Boada presented the MOPEAD project whic...

Members of the MOPEAD Communication Team travelled to Brussels this week to take part in an exciting Projects Communication Event organised by the Innovative Medicines Initiative (IMI) which brought together representatives from many IMI projects who...

We thrilled to announce that Project Coordinator Dr. Mercè Boada will present a lecture on MOPEAD on Saturday 16th February at the 11th Panhellenic Conference on Alzheimer's Disease & 3rd Mediterranean Conference on Neurodegenerative Diseases PICAD & MeCoN...

The MOPEAD Communication team is pleased to present the 2nd MOPEAD newsletter which brings all the latest news from the project together including an introduction from our Patient Association partner Spominčica - Alzheimer Slovenija and articles on the var...

 You can now watch the presentations given at the MOPEAD Symposium at the 28th Alzheimer Europe Conference on Alzheimer Europe's YouTube channel.

Watch project Coordinator Mercè Boada (Fundació ACE) present MOPEAD's rationale and objectives to understa...

Please reload

Please reload

©2018 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations